A Randomized, Multicenter, Placebo and Active-Controlled, Single-Dose, 4-Period, Crossover Study to Evaluate the Bronchodilating Effect of SYMBICORT pMDI Versus Advair Diskus and Ventolin HFA.
Sponsor study identifier
Secondary identifiers
interventional
48
0 countries
N/A
Study Start
April 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
September 2003
Actual (reported)The purpose of this study is to compare the early onset of effect of Symbicort compared to Advair Diskus and Ventolin in adults with asthma
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2003
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2003
Date type not reportedThis date has not been verified as actual or estimated.
September 2003
Actual (reported)March 26, 2008
Actual (reported)March 28, 2008
Actual (reported)FEV1 3 minutes post dose
4 assessments across 4 visits whilst on treatment (visits may be between 3 and 14 days apart)
12 hour serial FEV1
4 assessments across 4 visits whilst on treatment (visits may be between 3 and 14 days apart)
Patients perception of effect
4 assessments across 4 visits whilst on treatment (visits may be between 3 and 14 days apart)
budesonide/formoterol
fluticasone/salmeterol
albuterol
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Grouped treatment entry
budesonide/formoterol (Symbicort)
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordGrouped treatment entry
fluticasone/salmeterol (Advair Diskus)
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordCatherine Bonuccelli
AstraZeneca
48 participants (actual enrollment reported by the registry).
First Submitted
March 26, 2008
First Posted
March 28, 2008
Study Start
April 2003
Date type not reportedThis date has not been verified as actual or estimated.
Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Study Completion
September 2003
Actual (reported)Last Updated
April 6, 2009
Record last verified: 2009-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: